Cierpikowski Piotr, Lis-Nawara Anna, Gajdzis Pawel, Bar Julia
Department of Immunopathology and Molecular Biology, Wroclaw Medical University, Wroclaw, Poland
Department of Immunopathology and Molecular Biology, Wroclaw Medical University, Wroclaw, Poland.
Anticancer Res. 2018 Feb;38(2):795-802. doi: 10.21873/anticanres.12286.
The purpose of this study was to explore the parallel expression of platelet-derived growth factor receptor α (PDGFRα) and human epidermal growth factor receptor 2 (HER2) or p53 in relation to clinicopathological parameters of oral squamous cell carcinoma (OSCC) to define their role in progressive growth of tumor.
Expression of PDGFRα, HER2 and p53 was evaluated in 71 OSCC samples by immunohistochemistry. HER2 status was verified by fluorescence in situ hybridization.
PDGFRα and p53 expression were associated with tumor grade (p=0.043 and p=0.040, respectively). HER2 expression was more frequent in advanced (III/IV) cancer (p=0.006). A positive correlation of PDGFRα with HER2 (r=0.267; p=0.024) and with p53 (r=0.266; p=0.025) was noted. PDGFRα/HER2 and PDGFRα/p53 co-expression was found more often in G3 than in G1 and G2 tumors (p=0.008 and p=0.015, respectively).
Our study revealed that PDGFRα/HER2 and PDGFRα/p53 co-expression exists in poorly differentiated OSCCs, suggesting that cooperation between these proteins might enhance aggressive behavior of tumor.
本研究旨在探讨血小板衍生生长因子受体α(PDGFRα)与人类表皮生长因子受体2(HER2)或p53的平行表达与口腔鳞状细胞癌(OSCC)临床病理参数的关系,以确定它们在肿瘤进展生长中的作用。
采用免疫组织化学法评估71例OSCC样本中PDGFRα、HER2和p53的表达。通过荧光原位杂交验证HER2状态。
PDGFRα和p53表达与肿瘤分级相关(分别为p = 0.043和p = 0.040)。HER2表达在晚期(III/IV期)癌症中更常见(p = 0.006)。观察到PDGFRα与HER2呈正相关(r = 0.267;p = 0.024),与p53呈正相关(r = 0.266;p = 0.025)。PDGFRα/HER2和PDGFRα/p53共表达在G3肿瘤中比在G1和G2肿瘤中更常见(分别为p = 0.008和p = 0.015)。
我们的研究表明,PDGFRα/HER2和PDGFRα/p53共表达存在于低分化OSCC中,提示这些蛋白之间的协同作用可能增强肿瘤的侵袭性。